Phase 1 Patients With Advanced Solid Tumors Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
PM534 Administered Intravenously to Patients With Advanced Solid Tumors
Patients With Advanced Solid Tumors
PharmaMar30 enrolled3 locationsNCT05835609
Recruiting
Phase 1
Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial
Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments
Zhejiang University12 enrolled1 locationNCT07021534
Recruiting
Phase 1
ABOD2011 in Patients With Advanced Solid Tumors Progressed After Standard Systemic Therapy
Patients With Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences60 enrolled1 locationNCT05392699